BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 24097865)

  • 1. Effects of adjuvant chemoradiotherapy on the frequency and function of regulatory T cells in patients with head and neck cancer.
    Schuler PJ; Harasymczuk M; Schilling B; Saze Z; Strauss L; Lang S; Johnson JT; Whiteside TL
    Clin Cancer Res; 2013 Dec; 19(23):6585-96. PubMed ID: 24097865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic and functional characteristics of CD4+ CD39+ FOXP3+ and CD4+ CD39+ FOXP3neg T-cell subsets in cancer patients.
    Schuler PJ; Schilling B; Harasymczuk M; Hoffmann TK; Johnson J; Lang S; Whiteside TL
    Eur J Immunol; 2012 Jul; 42(7):1876-85. PubMed ID: 22585562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased frequency and suppressive activity of CD127(low/-) regulatory T cells in the peripheral circulation of patients with head and neck squamous cell carcinoma are associated with advanced stage and nodal involvement.
    Drennan S; Stafford ND; Greenman J; Green VL
    Immunology; 2013 Nov; 140(3):335-43. PubMed ID: 23826668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The frequency and suppressor function of CD4+CD25highFoxp3+ T cells in the circulation of patients with squamous cell carcinoma of the head and neck.
    Strauss L; Bergmann C; Gooding W; Johnson JT; Whiteside TL
    Clin Cancer Res; 2007 Nov; 13(21):6301-11. PubMed ID: 17975141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional and phenotypic characteristics of CD4+CD25highFoxp3+ Treg clones obtained from peripheral blood of patients with cancer.
    Strauss L; Bergmann C; Whiteside TL
    Int J Cancer; 2007 Dec; 121(11):2473-83. PubMed ID: 17691114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation of functional human regulatory T cells (Treg) from the peripheral blood based on the CD39 expression.
    Mandapathil M; Lang S; Gorelik E; Whiteside TL
    J Immunol Methods; 2009 Jul; 346(1-2):55-63. PubMed ID: 19450601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment.
    Strauss L; Bergmann C; Szczepanski M; Gooding W; Johnson JT; Whiteside TL
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4345-54. PubMed ID: 17671115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratumoral regulatory T cells upregulate immunosuppressive molecules in head and neck cancer patients.
    Jie HB; Gildener-Leapman N; Li J; Srivastava RM; Gibson SP; Whiteside TL; Ferris RL
    Br J Cancer; 2013 Nov; 109(10):2629-35. PubMed ID: 24169351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD45RA-Foxp3high but not CD45RA+Foxp3low suppressive T regulatory cells increased in the peripheral circulation of patients with head and neck squamous cell carcinoma and correlated with tumor progression.
    Sun W; Li WJ; Wu CY; Zhong H; Wen WP
    J Exp Clin Cancer Res; 2014 Apr; 33(1):35. PubMed ID: 24761979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cisplatin-based chemoradiation decreases telomerase-specific CD4 TH1 response but increases immune suppressive cells in peripheral blood.
    Boustani J; Joseph ELM; Martin E; Benhmida S; Lecoester B; Tochet F; Mirjolet C; Chevalier C; Thibouw D; Vulquin N; Servagi S; Sun X; Adotévi O
    BMC Immunol; 2021 Jun; 22(1):38. PubMed ID: 34144673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased ectonucleotidase expression and activity in regulatory T cells of patients with head and neck cancer.
    Mandapathil M; Szczepanski MJ; Szajnik M; Ren J; Lenzner DE; Jackson EK; Gorelik E; Lang S; Johnson JT; Whiteside TL
    Clin Cancer Res; 2009 Oct; 15(20):6348-57. PubMed ID: 19825957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamics of regulatory T cells (T
    Aggarwal S; Sharma SC; N Das S
    J Surg Oncol; 2017 Dec; 116(8):1103-1113. PubMed ID: 28833201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationships between regulatory T cells and CD8+ effector populations in patients with squamous cell carcinoma of the head and neck.
    Chikamatsu K; Sakakura K; Whiteside TL; Furuya N
    Head Neck; 2007 Feb; 29(2):120-7. PubMed ID: 17103408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic cell generation and CD4+ CD25high FOXP3+ regulatory t cells in human head and neck carcinoma during radio-chemotherapy.
    Schuler PJ; Börger V; Bölke E; Habermehl D; Matuschek C; Wild CA; Greve J; Bas M; Schilling B; Bergmann C; Trellakis S; Budach W; Gauler T; Brandau S; Lang S; Whiteside TL; Sorg RV; Hoffmann TK
    Eur J Med Res; 2011 Feb; 16(2):57-62. PubMed ID: 21463982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of tumor-associated T-lymphocyte subsets and immune checkpoint molecules in head and neck squamous cell carcinoma.
    Lechner A; Schlößer H; Rothschild SI; Thelen M; Reuter S; Zentis P; Shimabukuro-Vornhagen A; Theurich S; Wennhold K; Garcia-Marquez M; Tharun L; Quaas A; Schauss A; Isensee J; Hucho T; Huebbers C; von Bergwelt-Baildon M; Beutner D
    Oncotarget; 2017 Jul; 8(27):44418-44433. PubMed ID: 28574843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of CD4+CD25+ regulatory T cells in the peripheral circulation of patients with head and neck cancer.
    Schaefer C; Kim GG; Albers A; Hoermann K; Myers EN; Whiteside TL
    Br J Cancer; 2005 Mar; 92(5):913-20. PubMed ID: 15714205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Permanent up-regulation of regulatory T-lymphocytes in patients with head and neck cancer.
    Schott AK; Pries R; Wollenberg B
    Int J Mol Med; 2010 Jul; 26(1):67-75. PubMed ID: 20514424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The abnormal function of CD39
    Lu Y; Cheng L; Li F; Ji L; Shao X; Wu B; Zhan Y; Liu C; Min Z; Ke Y; Sun L; Chen H; Cheng Y
    Ann Hematol; 2019 Aug; 98(8):1845-1854. PubMed ID: 31154474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the composition of lymphocyte subpopulations in non-relapse and relapse patients with squamous cell carcinoma of the head and neck before, during radiochemotherapy and in the follow-up period: a multicenter prospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).
    Niu M; Combs SE; Linge A; Krause M; Baumann M; Lohaus F; Ebert N; Tinhofer I; Budach V; von der Grün J; Rödel F; Grosu AL; Multhoff G
    Radiat Oncol; 2021 Jul; 16(1):141. PubMed ID: 34332614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imbalance in absolute counts of T lymphocyte subsets in patients with head and neck cancer and its relation to disease.
    Kuss I; Hathaway B; Ferris RL; Gooding W; Whiteside TL
    Adv Otorhinolaryngol; 2005; 62():161-72. PubMed ID: 15608426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.